MENU

THTX Stock Tickeron detected bullish Stock Pattern: Triangle Descending THTX on December 03, 2024, netting in a 20.34% gain over 7 days

A.I.dvisor
at Tickeron.com
Loading...
+20.34% Gain from a Successful pattern Triangle Descending
THTX - Theratechnologies
Tickeron
Ticker: THTX
Company: Theratechnologies
Gain: +20.34%
Confirmed: 12/03/24
Succeeded: 12/04/24
Total length: 7 days
On November 27, 2024, A.I.dvisor detected a Triangle Descending Pattern (Bullish) for Theratechnologies (THTX, $1.18). On December 03, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $1.44. 1 day later, on December 04, 2024, THTX reached the target price resulting in a +2 for traders who took a long position in the stock.

THTX in upward trend: 10-day moving average crossed above 50-day moving average on December 04, 2024

The 10-day moving average for THTX crossed bullishly above the 50-day moving average on December 04, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 29, 2024. You may want to consider a long position or call options on THTX as a result. In of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for THTX just turned positive on December 02, 2024. Looking at past instances where THTX's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

THTX moved above its 50-day moving average on December 02, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where THTX advanced for three days, in of 214 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for THTX moved out of overbought territory on December 17, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THTX broke above its upper Bollinger Band on December 09, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. THTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). THTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.869) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com